The Houston Daily Post (Houston, Tex.), Vol. Thirteenth Year, No. 95, Ed. 1, Thursday, July 8, 1897 - Page 9 of 10 - The Portal to Texas History
Y<1stts T-, Kensett « Co. !!al timol"e, !bi. G<mtl-men: VI - 1 111 have the honot: to -'1<>r•rn-1th subl!lit
![Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/342851/lightbox_2fd4b770c11011ec8fab21444c2c7c53-Figure-4.png)
Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article
![Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/342879/lightbox_60b45af09f0811eca508e5ef1a3c5f79-Figure-7.png)